These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 12539227

  • 1. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia.
    Mirtti T, Alanen K, Kallajoki M, Rinne A, Söderström KO.
    Prostate; 2003 Mar 01; 54(4):290-8. PubMed ID: 12539227
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amphiregulin expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 93 cases.
    Bostwick DG, Qian J, Maihle NJ.
    Prostate; 2004 Feb 01; 58(2):164-8. PubMed ID: 14716741
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
    Weinstein MH, Signoretti S, Loda M.
    Mod Pathol; 2002 Dec 01; 15(12):1302-8. PubMed ID: 12481011
    [Abstract] [Full Text] [Related]

  • 7. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
    Sinha AA, Quast BJ, Reddy PK, Lall V, Wilson MJ, Qian J, Bostwick DG.
    Exp Mol Pathol; 2004 Oct 01; 77(2):153-9. PubMed ID: 15351240
    [Abstract] [Full Text] [Related]

  • 8. Comparative analysis of the nuclear proliferative index (Ki-67) in benign prostate, prostatic intraepithelial neoplasia, and prostatic carcinoma.
    Tamboli P, Amin MB, Schultz DS, Linden MD, Kubus J.
    Mod Pathol; 1996 Oct 01; 9(10):1015-9. PubMed ID: 8902840
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P, Amin MB, Xu HJ, Linden MD.
    Mod Pathol; 1998 Mar 01; 11(3):247-52. PubMed ID: 9521470
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.
    Am J Surg Pathol; 2007 Aug 01; 31(8):1246-55. PubMed ID: 17667550
    [Abstract] [Full Text] [Related]

  • 12. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
    Sasor A, Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2000 Aug 01; 51(1):31-6. PubMed ID: 10833901
    [Abstract] [Full Text] [Related]

  • 13. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I, McNeal JE, Ho SM, Jiang Z.
    Hum Pathol; 2003 Mar 01; 34(3):228-33. PubMed ID: 12673556
    [Abstract] [Full Text] [Related]

  • 14. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F, Epstein JI.
    Am J Surg Pathol; 2008 Jul 01; 32(7):1060-7. PubMed ID: 18496142
    [Abstract] [Full Text] [Related]

  • 15. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
    Helpap B, Bonkhoff H, Cockett A, Montironi R, Troncoso P, Waters D, Bostwick D.
    Pathologica; 1997 Jun 01; 89(3):288-300. PubMed ID: 9270265
    [Abstract] [Full Text] [Related]

  • 16. High-grade foamy gland prostatic adenocarcinoma on biopsy or transurethral resection: a morphologic study of 55 cases.
    Zhao J, Epstein JI.
    Am J Surg Pathol; 2009 Apr 01; 33(4):583-90. PubMed ID: 19033862
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG, Aiad HA, Sultan SM.
    APMIS; 2008 Nov 01; 116(11):961-71. PubMed ID: 19132993
    [Abstract] [Full Text] [Related]

  • 19. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.
    Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.
    Hum Pathol; 2007 Feb 01; 38(2):332-41. PubMed ID: 17134736
    [Abstract] [Full Text] [Related]

  • 20. Prostatic basal cells in the peripheral and transitional zones: zonal variation in morphology and in immunophenotype.
    Garcia FU, Haber MM, Chen X.
    Prostate; 2007 Nov 01; 67(15):1686-92. PubMed ID: 17879949
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.